Bionano Genomics (BNGO) Share-based Compensation (2017 - 2026)

Bionano Genomics (BNGO) has 10 years of Share-based Compensation data on file, last reported at $670000.0 in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation fell 57.78% year-over-year to $670000.0; the trailing twelve-month figure through Mar 2026 stood at $3.6 million (down 56.46% YoY), and the FY2025 full-year result was $4.5 million, down 53.43% from the prior year.
• Share-based Compensation slipped to $670000.0 in Q1 2026, from $926000.0 in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $21.9 million in Q4 2022 to a low of $4000.0 in Q2 2022.
• A 5-year average of $3.3 million and a median of $2.1 million in 2024 frame the typical range for Share-based Compensation.
• Across the five-year window, Share-based Compensation slumped 96.55% in 2022 and jumped 98200.0% in 2023, its largest moves.
• Tracing BNGO's Share-based Compensation over 5 years: stood at $21.9 million in 2022, then tumbled by 84.6% to $3.4 million in 2023, then plunged by 42.59% to $1.9 million in 2024, then tumbled by 52.17% to $926000.0 in 2025, then fell by 27.65% to $670000.0 in 2026.
• Business Quant data shows BNGO's Share-based Compensation at $670000.0 in Q1 2026, $926000.0 in Q4 2025, and $941000.0 in Q3 2025.